Description
WYC-210, a Tazarotene derivative, is a retinoid compound with lower anticancer activity.
Product information
CAS Number: 2131803-93-3
Molecular Weight: 340.40
Formula: C18H16N2O3S
Chemical Name: 2-[2-(4,4-dimethyl-1-oxo-3,4-dihydro-2H-1λ⁴-benzothiopyran-6-yl)ethynyl]pyrimidine-5-carboxylic acid
Smiles: CC1(C)CCS(=O)C2=CC=C(C=C12)C#CC1N=CC(=CN=1)C(O)=O
InChiKey: NENFGFHRYIOMTM-UHFFFAOYSA-N
InChi: InChI=1S/C18H16N2O3S/c1-18(2)7-8-24(23)15-5-3-12(9-14(15)18)4-6-16-19-10-13(11-20-16)17(21)22/h3,5,9-11H,7-8H2,1-2H3,(H,21,22)
Technical Data
Appearance: Solid Power
Purity: ≥98% (or refer to the Certificate of Analysis)
Solubility: DMSO : 50 mg/mL (146.89 mM; Need ultrasonic).
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life: ≥12 months if stored properly.
Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.
Drug Formulation: To be determined
HS Tariff Code: 382200
How to use
In Vitro:
WYC-210 (10 μM; 5 days) inhibits cell growth of B16-F1 TRC cells with an inhibition rate of 18.1%.
Products are for research use only. Not for human use.
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.